We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer Patients

This study has been terminated.
(The study needed to be terminated due to new knowledge about cancer vaccines. A new protocol with an expected more efficient vaccine is currently being written.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01334047
First Posted: April 12, 2011
Last Update Posted: August 25, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Oslo University Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: April 2022
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)